Skip to main content


Joseph MoskalDistinguished Research Professor of Biomedical Engineering and Join appointment with Neurological Surgery (MED)Director of the Falk Center for Molecular Therapeutics


Joseph Moskal is founder and chief scientific officer of Naurex, an Evanston-based drug discovery company that develops therapies for difficult-to-treat depression and other central nervous system diseases. Its therapeutics include two rapid-acting antidepressants currently in clinical development.

Classes Taught

NUvention: Therapeutics

Back to top